| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.5 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |